Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 34 Neoplasms 14 Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 8 Ovarian Neoplasms 7 Multiple Myeloma 6 Breast Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 4 Hematologic Neoplasms 4 Solid Tumors 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Gastrointestinal Neoplasms 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Solid Tumor 2 Skin Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Neoplasms by Histologic Type 2 Leukemia, Myelomonocytic, Chronic 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2

Interventions

Cyclophosphamide 4 Topotecan 3 Ifosfamide 3 Doxorubicin 3 seclidemstat 2 pazopanib 2 Biopsy 2 tebentafusp 1 selinexor 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 devimistat 1 cobimetinib 1 cabozantinib 1 atezolizumab 1 Zoledronic Acid 1 X-Rays 1 Vemurafenib 1 Sunitinib 1 Specimen Handling 1 Sirolimus 1 Simvastatin 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Clear Cell × cobimetinib × Clear all

NCT02968303 2020-06-05

COWBOY

Radboud University Medical Center

Phase 2 Unknown

Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡